1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Remimazolam: new trials by email Literature Review of Remimazolam trials Research Report on Remimazolam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Flumazenil Antagonism of Remimazolam in Kidney Transplant Patients Flumazenil Injection（F1 group）, Flumazenil Injection（F2 group）, Saline（C group） - Flumazenil to Antagonize Remimazolam, Remimazolam | Phase 1 | Unknown | Qianfoshan Hospital | 60 | 2024-07-01 | 2024-08-01 |
| Remimazolam for Emergence Delirium Prevention in Children Undergoing Tonsillectomy Remimazolam 20 MG Injection [Byfavo], NaCl (0,9%) - Remimazolam, Tonsillectomy | Phase 1 | Completed | University Hospital of Split | 110 | 2024-04-01 | 2026-07-15 |
Confusion (1) · Delirium (1) · Mental Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Postoperative Complications (1) · Signs and Symptoms (1)
Control Groups (1) · Injections (1) · remimazolam (1)
Qianfoshan Hospital (1) · University Hospital of Split (1)
Croatia (1)
Filip Peris (1)